Catalytic (glycosyltransferase) subunit of the bipartite ALG13-ALG14 UDP-N-acetylglucosamine transferase (GnTase). Together with the membrane-anchoring subunit ALG14, ALG13 catalyses the second step of dolichol-linked oligosaccharide (lipid-linked oligosaccharide, LLO) assembly on the cytoplasmic face of the endoplasmic reticulum membrane, transferring a beta-1,4-linked N-acetylglucosamine from UDP-GlcNAc onto GlcNAc-PP-dolichol to form the chitobiose core GlcNAc2-PP-dolichol (N,N'-diacetylchitobiosyl diphosphodolichol; EC 2.4.1.141). ALG13 provides the UDP-GlcNAc-binding/catalytic glycosyltransferase-28 (GT28) domain but lacks a membrane-spanning region and is recruited to the ER membrane by, and is catalytically active only in complex with, ALG14. The resulting chitobiosyl-PP-dolichol is the substrate for the next pathway enzyme (ALG1), feeding protein N-linked glycosylation. In humans, loss-of-function variants cause X-linked developmental and epileptic encephalopathy 36 (ALG13-CDG), an infantile-onset epileptic encephalopathy / infantile spasms phenotype with neurodevelopmental impairment.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0003824
catalytic activity
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: Root-level molecular function term from an ARBA electronic model. ALG13 is indeed a catalytic enzyme (a glycosyltransferase), but this term is far too general to be informative when the specific transferase activity is already annotated.
Reason: GO:0003824 (catalytic activity) is a top-level MF grouping term. The specific catalytic activity of ALG13 is captured by GO:0004577; this generic term adds no functional information.
|
|
GO:0004577
N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: This is the correct core molecular function (EC 2.4.1.141) mapped electronically from RHEA/EC. It is fully supported by direct experimental evidence (see the IDA and IMP annotations to the same term).
Reason: Matches the biochemically demonstrated activity of the ALG13/ALG14 complex and is the correct EC 2.4.1.141 term. This is a core function of ALG13.
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: Generic cytoplasm localization from an ARBA electronic model. ALG13 is a peripheral membrane protein acting on the cytoplasmic face of the ER membrane rather than free in the cytoplasm, and this is captured more precisely by GO:0098554 and GO:0005789.
Reason: ALG13 without ALG14 partitions to the cytosol, but its functional location is the cytoplasmic face of the ER membrane. GO:0005737 is imprecise and less informative than the ER-membrane annotations already present.
Supporting Evidence:
file:human/ALG13/ALG13-uniprot.txt
Recruited to the cytosolic face of the endoplasmic reticulum
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: ER membrane localization mapped from the UniProt Subcellular Location vocabulary. Correct core localization, consistent with the experimental evidence.
Reason: ALG13 is a peripheral ER-membrane protein recruited to the ER membrane by ALG14; the localization is experimentally supported.
Supporting Evidence:
file:human/ALG13/ALG13-uniprot.txt
Endoplasmic reticulum membrane
file:human/ALG13/ALG13-uniprot.txt
Peripheral membrane protein
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Core biological process, mapped from InterPro (Alg13-like family). ALG13 catalyses the second sugar-addition step of dolichol-linked (lipid-linked) oligosaccharide assembly and is fully supported by experimental evidence.
Reason: The ALG13/ALG14 complex synthesizes GlcNAc2-PP-dolichol, the second step of LLO assembly; this is a core process for ALG13.
Supporting Evidence:
PMID:16100110
required for the synthesis of the LLO
|
|
GO:0016758
hexosyltransferase activity
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: Parent/grouping term for the specific N-acetylglucosaminyltransferase activity. Correct but too general given the precise EC 2.4.1.141 term (GO:0004577) is present and experimentally supported.
Reason: GO:0016758 (hexosyltransferase activity) is an ancestor of the specific demonstrated activity GO:0004577. Replace with the specific term.
Proposed replacements:
N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Bare "protein binding" from a proteome-scale AP-MS interactome (BioPlex 3.0), with SLC2A4 (P14672) as the interactor. This is an uninformative MF term derived from a high-throughput dataset and does not capture the biologically meaningful ALG13-ALG14 interaction.
Reason: GO:0005515 (protein binding) conveys no specific molecular function and the SLC2A4 pairing is a high-throughput AP-MS association rather than a validated functional interaction. The biologically relevant partner is ALG14; ALG13-ALG14 complex membership is captured in core_functions (GO:0043541). Per curation policy, bare protein binding IPIs are marked as over-annotated rather than removed.
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-446207 |
ACCEPT |
Summary: ER membrane localization asserted by Reactome for the reaction in which the ALG13:ALG14 complex adds the second GlcNAc to GlcNAc-PP-dolichol. Correct core localization.
Reason: Consistent with the experimental ER-membrane localization; the Reactome reaction places the ALG13:ALG14 complex at the ER membrane.
Supporting Evidence:
Reactome:R-HSA-446207
This reaction is catalyzed by the ALG13:ALG14 complex
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-5633241 |
ACCEPT |
Summary: ER membrane localization asserted by Reactome (defective-ALG14 variant reaction). Redundant with the other ER-membrane annotations but correct.
Reason: Correct core ER-membrane localization for the ALG13:ALG14 complex.
|
|
GO:0005789
endoplasmic reticulum membrane
|
EXP
PMID:16100110 Alg14 recruits Alg13 to the cytoplasmic face of the endoplas... |
ACCEPT |
Summary: Experimental ER-membrane localization. Gao et al. showed ALG13/Alg13 associates with the ER membrane and is recruited to the cytosolic face of the ER by ALG14/Alg14.
Reason: Directly experimentally supported core localization.
Supporting Evidence:
PMID:16100110
as a membrane anchor that recruits Alg13 to the cytosolic face of the ER, where
|
|
GO:0098554
cytoplasmic side of endoplasmic reticulum membrane
|
IGI
PMID:16100110 Alg14 recruits Alg13 to the cytoplasmic face of the endoplas... |
ACCEPT |
Summary: Precise localization to the cytoplasmic face of the ER membrane, the site where the ALG13/ALG14 complex catalyses formation of GlcNAc2-PP-dolichol. Supported by genetic interaction evidence in the Gao et al. study.
Reason: This is the most specific and functionally accurate localization for ALG13; catalysis of GlcNAc2-PP-dol occurs on the cytosolic face of the ER.
Supporting Evidence:
PMID:16100110
catalysis of GlcNAc2-PP-dol occurs
|
|
GO:0004577
N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
|
IDA
PMID:36200043 An in vitro assay for enzymatic studies on human ALG13/14 he... |
ACCEPT |
Summary: Direct in vitro demonstration of GnTase (EC 2.4.1.141) activity of the purified human ALG13/ALG14 heterodimer, using synthesized GlcNAc-PP-dolichol acceptor and UDP-GlcNAc donor. This is the strongest evidence for the core molecular function.
Reason: Directly measured biochemical activity; core molecular function of ALG13.
Supporting Evidence:
PMID:36200043
This dimeric ALG13/14 catalyzes the second step of LLO synthesis, transferring a β1,4-linked N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to GlcNAc-pyrophosphate-dolichol (Gn-PDol)
PMID:36200043
only the shorter human ALG13 isoform 2, but
|
|
GO:0006487
protein N-linked glycosylation
|
IMP
PMID:22492991 Gene identification in the congenital disorders of glycosyla... |
KEEP AS NON CORE |
Summary: ALG13 acts upstream of protein N-linked glycosylation; its direct molecular step (adding the second GlcNAc to make GlcNAc2-PP-dolichol) feeds the LLO precursor that is ultimately transferred to nascent proteins. Timal et al. identified an X-linked ALG13 CDG-I defect and confirmed deficient enzyme activity in patient fibroblasts.
Reason: N-linked glycosylation is the pathway ALG13 feeds, but ALG13's own catalytic step is LLO GlcNAc2 formation (GO:0006488 / GO:0004577). The upstream-effect relationship to N-glycosylation is correct and worth retaining, but it is a downstream process rather than ALG13's direct core function.
Supporting Evidence:
PMID:22492991
the first X-linked CDG-I due to a de novo mutation in
PMID:22492991
The pathogenicity of the mutations
|
|
GO:0004577
N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
|
IMP
PMID:22492991 Gene identification in the congenital disorders of glycosyla... |
ACCEPT |
Summary: Mutational (patient-derived) evidence that ALG13 provides EC 2.4.1.141 activity; the CDG-I defect was confirmed by deficient enzyme activity in patient fibroblasts. Duplicate of the core MF term with independent evidence.
Reason: Independent (IMP) support for the core molecular function; deficient GnTase activity in ALG13-CDG patient cells confirms this is ALG13's activity.
Supporting Evidence:
PMID:22492991
was confirmed by showing the deficient activity
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IMP
PMID:22492991 Gene identification in the congenital disorders of glycosyla... |
ACCEPT |
Summary: Mutational evidence that ALG13 is required for dolichol-linked oligosaccharide biosynthesis; ALG13 catalyses the second of the first two steps of dolichol-PP-glycan assembly. Core biological process.
Reason: ALG13 performs a required step of LLO assembly; patient variants impair the pathway. Core process for ALG13.
Supporting Evidence:
PMID:22492991
together the first two steps in dolichol-PP-glycan assembly
|
|
GO:0043541
UDP-N-acetylglucosamine transferase complex
|
IDA
file:human/ALG13/ALG13-uniprot.txt |
NEW |
Summary: ALG13 is an active subunit of the ALG13-ALG14 UDP-N-acetylglucosamine transferase complex. This complex-membership term is recorded in the UniProt GO cross-references (IDA:UniProtKB) but is absent from the GOA TSV under review; added here as it is the biologically correct complex for ALG13's activity.
Reason: ALG13 has GnTase activity only when bound to ALG14 in the heterodimeric complex; complex membership (GO:0043541) is well supported and more informative than the bare protein-binding IPI.
Supporting Evidence:
PMID:16100110
as a membrane anchor that recruits Alg13 to the cytosolic face of the ER, where
PMID:36200043
only the shorter human ALG13 isoform 2, but
Reactome:R-HSA-446207
This reaction is catalyzed by the ALG13:ALG14 complex
|
ALG13 is the catalytic (glycosyltransferase) subunit of the bipartite
ALG13/ALG14 UDP-N-acetylglucosamine transferase (GnTase) that catalyses the
second step of dolichol-linked oligosaccharide (LLO) assembly in the ER: transfer of
the second N-acetylglucosamine (β1,4-linked) from UDP-GlcNAc onto GlcNAc-PP-dolichol
to form the chitobiose core GlcNAc2-PP-dolichol (N,N'-diacetylchitobiosyl
diphosphodolichol). EC 2.4.1.141 = GO:0004577.
Pathogenic ALG13 variants cause X-linked developmental and epileptic encephalopathy 36
(DEE36 / ALG13-CDG) — infantile spasms / early-onset epileptic encephalopathy with
neurodevelopmental impairment. Some patients show abnormal transferrin isoelectric
focusing (CDG type I biomarker), though many ALG13-CDG variants have near-normal
transferrin. CDG variants (e.g. K94E, N107S) reduce GnTase activity in vitro.
[PMID:22492991, PMID:36200043, PMID:23934111, PMID:26138355]
UniProt DR block records GO:0043541 (UDP-N-acetylglucosamine transferase complex, IDA) — used
in core_functions in_complex.
id: Q9NP73
gene_symbol: ALG13
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: Catalytic (glycosyltransferase) subunit of the bipartite ALG13-ALG14
UDP-N-acetylglucosamine transferase (GnTase). Together with the membrane-anchoring
subunit ALG14, ALG13 catalyses the second step of dolichol-linked oligosaccharide
(lipid-linked oligosaccharide, LLO) assembly on the cytoplasmic face of the endoplasmic
reticulum membrane, transferring a beta-1,4-linked N-acetylglucosamine from UDP-GlcNAc
onto GlcNAc-PP-dolichol to form the chitobiose core GlcNAc2-PP-dolichol (N,N'-diacetylchitobiosyl
diphosphodolichol; EC 2.4.1.141). ALG13 provides the UDP-GlcNAc-binding/catalytic
glycosyltransferase-28 (GT28) domain but lacks a membrane-spanning region and is
recruited to the ER membrane by, and is catalytically active only in complex with,
ALG14. The resulting chitobiosyl-PP-dolichol is the substrate for the next pathway
enzyme (ALG1), feeding protein N-linked glycosylation. In humans, loss-of-function
variants cause X-linked developmental and epileptic encephalopathy 36 (ALG13-CDG),
an infantile-onset epileptic encephalopathy / infantile spasms phenotype with
neurodevelopmental impairment.
alternative_products:
- name: '1'
id: Q9NP73-1
- name: '2'
id: Q9NP73-2
sequence_note: VSP_039301, VSP_039302
- name: '3'
id: Q9NP73-3
sequence_note: VSP_039299, VSP_039300
- name: '4'
id: Q9NP73-4
sequence_note: VSP_039298, VSP_039303
existing_annotations:
- term:
id: GO:0003824
label: catalytic activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: Root-level molecular function term from an ARBA electronic model. ALG13
is indeed a catalytic enzyme (a glycosyltransferase), but this term is far too
general to be informative when the specific transferase activity is already
annotated.
action: MARK_AS_OVER_ANNOTATED
reason: GO:0003824 (catalytic activity) is a top-level MF grouping term. The specific
catalytic activity of ALG13 is captured by GO:0004577; this generic term adds
no functional information.
- term:
id: GO:0004577
label: N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: This is the correct core molecular function (EC 2.4.1.141) mapped electronically
from RHEA/EC. It is fully supported by direct experimental evidence (see the
IDA and IMP annotations to the same term).
action: ACCEPT
reason: Matches the biochemically demonstrated activity of the ALG13/ALG14 complex
and is the correct EC 2.4.1.141 term. This is a core function of ALG13.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: located_in
review:
summary: Generic cytoplasm localization from an ARBA electronic model. ALG13 is
a peripheral membrane protein acting on the cytoplasmic face of the ER membrane
rather than free in the cytoplasm, and this is captured more precisely by GO:0098554
and GO:0005789.
action: MARK_AS_OVER_ANNOTATED
reason: ALG13 without ALG14 partitions to the cytosol, but its functional location
is the cytoplasmic face of the ER membrane. GO:0005737 is imprecise and less
informative than the ER-membrane annotations already present.
supported_by:
- reference_id: file:human/ALG13/ALG13-uniprot.txt
supporting_text: Recruited to the cytosolic face of the endoplasmic reticulum
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: ER membrane localization mapped from the UniProt Subcellular Location
vocabulary. Correct core localization, consistent with the experimental evidence.
action: ACCEPT
reason: ALG13 is a peripheral ER-membrane protein recruited to the ER membrane
by ALG14; the localization is experimentally supported.
supported_by:
- reference_id: file:human/ALG13/ALG13-uniprot.txt
supporting_text: Endoplasmic reticulum membrane
- reference_id: file:human/ALG13/ALG13-uniprot.txt
supporting_text: Peripheral membrane protein
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: Core biological process, mapped from InterPro (Alg13-like family). ALG13
catalyses the second sugar-addition step of dolichol-linked (lipid-linked) oligosaccharide
assembly and is fully supported by experimental evidence.
action: ACCEPT
reason: The ALG13/ALG14 complex synthesizes GlcNAc2-PP-dolichol, the second step
of LLO assembly; this is a core process for ALG13.
supported_by:
- reference_id: PMID:16100110
supporting_text: required for the synthesis of the LLO
- term:
id: GO:0016758
label: hexosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: Parent/grouping term for the specific N-acetylglucosaminyltransferase
activity. Correct but too general given the precise EC 2.4.1.141 term (GO:0004577)
is present and experimentally supported.
action: MODIFY
reason: GO:0016758 (hexosyltransferase activity) is an ancestor of the specific
demonstrated activity GO:0004577. Replace with the specific term.
proposed_replacement_terms:
- id: GO:0004577
label: N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: Bare "protein binding" from a proteome-scale AP-MS interactome (BioPlex
3.0), with SLC2A4 (P14672) as the interactor. This is an uninformative MF term
derived from a high-throughput dataset and does not capture the biologically
meaningful ALG13-ALG14 interaction.
action: MARK_AS_OVER_ANNOTATED
reason: 'GO:0005515 (protein binding) conveys no specific molecular function and
the SLC2A4 pairing is a high-throughput AP-MS association rather than a validated
functional interaction. The biologically relevant partner is ALG14; ALG13-ALG14
complex membership is captured in core_functions (GO:0043541). Per curation
policy, bare protein binding IPIs are marked as over-annotated rather than removed.'
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-446207
qualifier: located_in
review:
summary: ER membrane localization asserted by Reactome for the reaction in which
the ALG13:ALG14 complex adds the second GlcNAc to GlcNAc-PP-dolichol. Correct
core localization.
action: ACCEPT
reason: Consistent with the experimental ER-membrane localization; the Reactome
reaction places the ALG13:ALG14 complex at the ER membrane.
supported_by:
- reference_id: Reactome:R-HSA-446207
supporting_text: This reaction is catalyzed by the ALG13:ALG14 complex
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5633241
qualifier: located_in
review:
summary: ER membrane localization asserted by Reactome (defective-ALG14 variant
reaction). Redundant with the other ER-membrane annotations but correct.
action: ACCEPT
reason: Correct core ER-membrane localization for the ALG13:ALG14 complex.
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: EXP
original_reference_id: PMID:16100110
qualifier: located_in
review:
summary: Experimental ER-membrane localization. Gao et al. showed ALG13/Alg13 associates
with the ER membrane and is recruited to the cytosolic face of the ER by ALG14/Alg14.
action: ACCEPT
reason: Directly experimentally supported core localization.
supported_by:
- reference_id: PMID:16100110
supporting_text: as a membrane anchor that recruits Alg13 to the cytosolic face
of the ER, where
- term:
id: GO:0098554
label: cytoplasmic side of endoplasmic reticulum membrane
evidence_type: IGI
original_reference_id: PMID:16100110
qualifier: is_active_in
review:
summary: Precise localization to the cytoplasmic face of the ER membrane, the site
where the ALG13/ALG14 complex catalyses formation of GlcNAc2-PP-dolichol. Supported
by genetic interaction evidence in the Gao et al. study.
action: ACCEPT
reason: This is the most specific and functionally accurate localization for ALG13;
catalysis of GlcNAc2-PP-dol occurs on the cytosolic face of the ER.
supported_by:
- reference_id: PMID:16100110
supporting_text: catalysis of GlcNAc2-PP-dol occurs
- term:
id: GO:0004577
label: N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
evidence_type: IDA
original_reference_id: PMID:36200043
qualifier: enables
review:
summary: Direct in vitro demonstration of GnTase (EC 2.4.1.141) activity of the
purified human ALG13/ALG14 heterodimer, using synthesized GlcNAc-PP-dolichol
acceptor and UDP-GlcNAc donor. This is the strongest evidence for the core molecular
function.
action: ACCEPT
reason: Directly measured biochemical activity; core molecular function of ALG13.
supported_by:
- reference_id: PMID:36200043
supporting_text: This dimeric ALG13/14 catalyzes the second step of LLO synthesis,
transferring a β1,4-linked N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to
GlcNAc-pyrophosphate-dolichol (Gn-PDol)
- reference_id: PMID:36200043
supporting_text: only the shorter human ALG13 isoform 2, but
- term:
id: GO:0006487
label: protein N-linked glycosylation
evidence_type: IMP
original_reference_id: PMID:22492991
qualifier: acts_upstream_of_positive_effect
review:
summary: ALG13 acts upstream of protein N-linked glycosylation; its direct molecular
step (adding the second GlcNAc to make GlcNAc2-PP-dolichol) feeds the LLO precursor
that is ultimately transferred to nascent proteins. Timal et al. identified an
X-linked ALG13 CDG-I defect and confirmed deficient enzyme activity in patient
fibroblasts.
action: KEEP_AS_NON_CORE
reason: N-linked glycosylation is the pathway ALG13 feeds, but ALG13's own catalytic
step is LLO GlcNAc2 formation (GO:0006488 / GO:0004577). The upstream-effect
relationship to N-glycosylation is correct and worth retaining, but it is a
downstream process rather than ALG13's direct core function.
supported_by:
- reference_id: PMID:22492991
supporting_text: the first X-linked CDG-I due to a de novo mutation in
- reference_id: PMID:22492991
supporting_text: The pathogenicity of the mutations
- term:
id: GO:0004577
label: N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
evidence_type: IMP
original_reference_id: PMID:22492991
qualifier: enables
review:
summary: Mutational (patient-derived) evidence that ALG13 provides EC 2.4.1.141
activity; the CDG-I defect was confirmed by deficient enzyme activity in patient
fibroblasts. Duplicate of the core MF term with independent evidence.
action: ACCEPT
reason: Independent (IMP) support for the core molecular function; deficient GnTase
activity in ALG13-CDG patient cells confirms this is ALG13's activity.
supported_by:
- reference_id: PMID:22492991
supporting_text: was confirmed by showing the deficient activity
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IMP
original_reference_id: PMID:22492991
qualifier: involved_in
review:
summary: Mutational evidence that ALG13 is required for dolichol-linked oligosaccharide
biosynthesis; ALG13 catalyses the second of the first two steps of dolichol-PP-glycan
assembly. Core biological process.
action: ACCEPT
reason: ALG13 performs a required step of LLO assembly; patient variants impair
the pathway. Core process for ALG13.
supported_by:
- reference_id: PMID:22492991
supporting_text: together the first two steps in dolichol-PP-glycan assembly
- term:
id: GO:0043541
label: UDP-N-acetylglucosamine transferase complex
evidence_type: IDA
original_reference_id: file:human/ALG13/ALG13-uniprot.txt
qualifier: part_of
review:
summary: ALG13 is an active subunit of the ALG13-ALG14 UDP-N-acetylglucosamine
transferase complex. This complex-membership term is recorded in the UniProt
GO cross-references (IDA:UniProtKB) but is absent from the GOA TSV under review;
added here as it is the biologically correct complex for ALG13's activity.
action: NEW
reason: ALG13 has GnTase activity only when bound to ALG14 in the heterodimeric
complex; complex membership (GO:0043541) is well supported and more informative
than the bare protein-binding IPI.
supported_by:
- reference_id: PMID:16100110
supporting_text: as a membrane anchor that recruits Alg13 to the cytosolic face
of the ER, where
- reference_id: PMID:36200043
supporting_text: only the shorter human ALG13 isoform 2, but
- reference_id: Reactome:R-HSA-446207
supporting_text: This reaction is catalyzed by the ALG13:ALG14 complex
core_functions:
- description: Catalytic subunit of the ALG13-ALG14 UDP-N-acetylglucosamine transferase;
transfers the second (beta-1,4-linked) GlcNAc from UDP-GlcNAc onto GlcNAc-PP-dolichol
to form GlcNAc2-PP-dolichol (chitobiose core), the second step of dolichol-linked
oligosaccharide (LLO) assembly.
molecular_function:
id: GO:0004577
label: N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity
directly_involved_in:
- id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
locations:
- id: GO:0098554
label: cytoplasmic side of endoplasmic reticulum membrane
- id: GO:0005789
label: endoplasmic reticulum membrane
in_complex:
id: GO:0043541
label: UDP-N-acetylglucosamine transferase complex
supported_by:
- reference_id: PMID:36200043
supporting_text: This dimeric ALG13/14 catalyzes the second step of LLO synthesis,
transferring a β1,4-linked N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to GlcNAc-pyrophosphate-dolichol
(Gn-PDol)
- reference_id: PMID:16100110
supporting_text: as a membrane anchor that recruits Alg13 to the cytosolic face
of the ER, where
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:16100110
title: Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic reticulum
to form a novel bipartite UDP-N-acetylglucosamine transferase required for the
second step of N-linked glycosylation.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Establishes the bipartite ALG13/ALG14 UDP-GlcNAc transferase, ALG14
as membrane anchor recruiting ALG13 to the cytosolic face of the ER, and the
second-step catalysis producing GlcNAc2-PP-dolichol. Human ALG13/ALG14 complement
yeast mutants. Abstract-only in cache; assertions used are in the abstract.
- id: PMID:22492991
title: Gene identification in the congenital disorders of glycosylation type I by
whole-exome sequencing.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Identified the first X-linked CDG-I due to a de novo ALG13 mutation
(DEE36/ALG13-CDG); pathogenicity confirmed by deficient enzyme activity in patient
fibroblasts. Abstract-only in cache; supports the disease and pathway roles.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: BioPlex 3.0 proteome-scale AP-MS interactome; source of the bare
protein-binding IPI (ALG13-SLC2A4). High-throughput dataset, not a targeted
functional study of ALG13; the specific pair is not discussed in the cached text.
- id: PMID:36200043
title: An in vitro assay for enzymatic studies on human ALG13/14 heterodimeric UDP-N-acetylglucosamine
transferase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Full-text cached. Purified human ALG13/ALG14 heterodimer shows GnTase
(EC 2.4.1.141) activity in a quantitative LC-MS assay; only short isoform 2
(not long isoform 1) forms an active complex with ALG14; CDG variants reduce
activity, linking GnTase deficiency to ALG13/14-CDG.
- id: Reactome:R-HSA-446207
title: ALG13:ALG14 transfers GlcNAc from UDP-GlcNAc to GlcNAcDOLP
findings: []
- id: Reactome:R-HSA-5633241
title: Defective ALG14 does not transfer GlcNAc from UDP-GlcNAc to GlcNAcDOLP
findings: []
- id: file:human/ALG13/ALG13-uniprot.txt
title: UniProtKB entry Q9NP73 (ALG13_HUMAN)
findings: []